The consistent diagnosis of endogenous psychoses, which under Kraepeliri's influence seemed to have been achieved around the turn of the century, has now become lost again after only a few decades. Only Kraepelin's dichotomy (1) which established a distinction in the field of endogenous psychoses between dementia praecox and manic depressive psychoses remains valid. Most of what appeared to be scientifically sound, however, has again become doubtful: relativity in the concept of "endogenous;" the difficulty of making a clear distinction between the two entities; the unreliability of all systems of classification so far attempted. Controversies which at first were mostly concerned with schizophrenic psychoses have been extended since the second world war to the realm of depressive psychoses. New forms havebeen described, such as Schneider's "Untergrunddepression" (2), L6pez Ibor's "anxiety thymopathy" (3), Weitbrecht.'s "endo-reactive dysthymia" (4). The part played by reactive and somatic factors in endogenous depressive states has been thoroughly investigated, particularly in central Europe where the recent catastrophic experiences have provided valuable opportunities for study. As to the nosology of endogenous psychoses, decades of argument have not resulted in agreement, only in agreement to differ. It is questionable whether there is in fact any point in arguing about the classification of endogenous psychoses. The most varied endogenous states can be described from the course of the disease and from their psychopathologic symptomatology. Whether different diseases and different pathologic groups are really being described remains very doubtful.
characterize the psychopathological picture by the specific nature of the fundamental dynamic disorder, the therapy of psychoses would be greatly helped, since the somatic methods of treatment, and particularly the psychotropic drugs, appear mainly to affect the psychic dynamics.
Elsewhere (9) we have attempted to describe four basic dynamic states and to use them to distinguish different types of endogenous psychoses. These are:
1. Dynamic reduction. This is characterized by impoverishment, narrowing and loss of flexibility of the psychic dynamics. As a fundamental state it is found mainly in depressive psychoses.
2. Dynamic expansion, expressing itself in loosening, freeing and heightening of the dynamic process in manic psychoses.
*Translation.
""Attending Psychiatrist, University of Mainz Psychiatric Clinic, Municipal Hospital, Mainz, Germany. S195 S196 CANADIAN PSYCHIATRIC ASSOCIATION JOURNAL Vol. 4, 1959 3. Dynamic unsteadiness found in acute schizophrenic psychoses. 4. Dynamic emptying as a general dynamic insufficiency in defective schizophrenic psychoses.
It is beyond the scope of this article to describe in detail these fundamental states, which in specific cases may overlap and occur concurrently. We shall limit ourselves to discussing the consequences of this dynamistic concept for the pharmacotherapy of psychoses.
The introduction of chlorpromazine and reserpine may be regarded as marking the beginning of the effective pharmacotherapy of endogenous psychoses. At that time only the thymoplegic principle (7-9) was available. The action of these two drugs (l0, 11) is stabilizing and suppressive in the emotional-intentional sphere. From the dynamistic point of view, the effectiveness of thymoplegic therapy has been found to be quite independent of the diagnosis. The more agitated the psychosis, the more successful is the treatment likely to be, whether the condition is one of a manic or of an acute schizophrenic nature. Even some agitated depressions may be influenced up to a point, whereas the majority of depressions and the bland schizophrenic disorders are hardly affected by the treatment. Regardless of the diagnostic classification, the thymoplegic principle acts wherever the salient feature is a raising of the dynamic level or an excitation of unsteadiness of the dynamic process. We are mainly indebted to C. and H. Selbach (12) for a somatological explanation of this state of affairs.
With the introduction of iproniazid and Tofranil" we have examples of a quite different therapeutic principle, one which-like convulsive therapy-makes possible a continuous activation of the psychic dynamics. Differences in the mode of action of the two drugs are shown by the fact that iproniazid has an activating and stimulating effect even on normal persons, whereas Tofranil develops its thymoleptic action (13) when the dynamic level is lowered. As shown by the extensive studies of Schmitt with Tofranil (14) and also by our own work with both Tofranil and iproniazid, the patients most readily responsive are those suffering from inhibitional vital depressions. We have also been successful in cases of dynamic emptying, in bland schizophrenias and even in adynamic non-psychotic states of exhaustion and depressive moods. If the initial dynamic state is ignored, surprising results may be observed when an activating therapeutic drug is used: schizophrenic psychoses may suddenly flare up again, depressed patients may become more agitated; in cases of agitated involutional depression neither previously nor subsequently schizophrenic, delusions or even acoustic hallucinations may be caused, as we have found with iproniazid. Our first impression is that Tofranil has a more continuous, less "thyrneretic" effect; it is clearly less likely than iproniazid to produce "atypical" symptoms. We would like to stress once more that in pharmacotherapy it is not the diagnosis which is decisive but the character of the fundamental dynamic process.
The view that thyrnoleptics represent something entirely new in the pharmacotherapy of depressive psychoses is opposed by the fact that the analeptic arnines, in spite of their known action, have failed in the treatment of depressions. But it is just this fact which points clearly to the primary effect in the pharmacotherapy of psychoses: the therapeutic effectiveness of both thymoplegics and thymoleptics depends mainly on their capacity to stabilize the dynamic process and to lower or raise the energetic level permanently. Of particular significance, furthermore, is the direct action of thymotropic substances on emotivity, an action which the analeptic amines do not possess. In the development of new psychotherapeutic drugs, preference should be given to substances having an elective thymotropic effect yet acting with sufficient continuity to achieve a consolidation of the dynamic process *Trade Mark.
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DEPRESSION AND ALLIED STATES S197 at the desired therapeutic level. We already have a sufficiency of thymoplegics, There are good grounds for the hope that we are only at the beginning of the development of thymoleptic drugs and above all of the pharmacotherapy of depressive psychoses.
Resume
La classification des psychoses endogenes s'entoure de tant de complexite et de controverse qu'il vaut mieux les reconsiderer comme etant des formes psychopathologiques variees d'un seul phenomene. Ces formes peuvent~tre classifiees dynamiquement en quatre classes: reduction dynamique, expansion dynamique, instabilite dynamique, et insuffisance dynamique. En fonction de ces etats dynamiques, on decrit l'effet de differents medicaments sur les psychoses endogenes, et l'action specifique du Tofranil est comparee d'une part avec celle d'agents thymoplegiques (chlorpromazine et reserpine), et d'autre part avec celle de l'iproniazide.
Il semble que Tofranil, dans les cas de psychoses endogenes, compare aI'iproniazide est moins susceptible de produire des syrnptomes atypiques.
